Profile
Jason G.
Duncan currently works as a Software Engineer at American Panel Corp.
and as Chief Legal & Administrative Officer at enGene Therapeutics, Inc. Former positions include Associate General Counsel at EMD Serono, Inc. from 2011 to 2014; Vice President, Head-Compliance & Legal at Swedish Orphan Biovitrum AB from 2014 to 2015; Vice President, Head-Compliance & Legal at Sobi, Inc. from 2014 to 2015; General Counsel at Stallergenes Greer, Inc. from 2015 to 2018; Secretary, Chief Legal Officer & General Counsel at Albireo Pharma, Inc.; and Chief Legal & Administrative Officer at Neumora Therapeutics, Inc. Education includes undergraduate studies at Dickinson College and graduate studies at Suffolk University Law School.
Jason Duncan active positions
| Companies | Position | Start |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Chief Administrative Officer | 09/11/2026 |
American Panel Corp.
American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems | Chief Tech/Sci/R&D Officer | - |
Former positions of Jason Duncan
| Companies | Position | End |
|---|---|---|
Stallergenes Greer, Inc.
Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | General Counsel | 01/06/2018 |
Sobi, Inc.
Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Compliance Officer | 01/10/2015 |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01/08/2015 |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | 01/07/2014 |
| ALBIREO PHARMA, INC. | General Counsel | - |
Education of Jason Duncan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Panel Corp.
American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems | Consumer Durables |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Suffolk University Law School
Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Stallergenes Greer, Inc.
Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | Health Technology |
Sobi, Inc.
Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Commercial Services |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
enGene Holdings, Inc.
enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
- Stock Market
- Insiders
- Jason Duncan
















